Literature DB >> 8722225

Regional differences in the incidence and treatment of carcinoma in situ of the breast.

W S Choi1, B A Parker, J P Pierce, E R Greenberg.   

Abstract

Greater use of mammography in the United States in recent years has increased the detection of early neoplasms of the breast, including carcinoma in situ. However, the occurrence and treatment of diagnosed carcinoma in situ of the breast has not been fully described. Our goal was to examine temporal, geographic, and demographic patterns in the incidence and treatment of in situ breast cancer. The study included data from all women with in situ breast cancer that had been detected in the nine Surveillance, Epidemiology, and End Results areas of the United States from 1975 through 1990 (Surveillance Program, Cancer Statistics Branch, Bethesda, MD: National Cancer Institute, November, 1993). We calculated age-adjusted incidence rates (1970 United States standard) using data on histology and treatment from the Surveillance, Epidemiology, and End Results data tape. We assessed predictors of treatment by mastectomy using multiple logistic regression. From 1975-1979 to 1986-1990, the age-adjusted incidence rate of in situ breast cancer increased from 4.7 to 16.9/100,000 women. The increase occurred in all age groups and among both white and black women. However, there was nearly a 2-fold difference in incidence rates across geographic areas in 1986-1990, ranging from < 12/100,000 in Iowa and New Mexico to > 20/100,000 in San Francisco and Seattle. Geographic variability in treatment was also evident, with mastectomy, rather than breast-conserving therapy, performed on 46% of the women with in situ breast cancer in San Francisco and on 66% of those in Iowa. The incidence of diagnosed in situ breast cancer increased markedly during the 1980s, and there was substantial geographic variability in the rates of detection of these tumors and in the type of therapy received. Although mastectomy became a less common treatment over time, it was still performed on a high proportion of women with in situ breast cancer during the latter part of the decade.

Entities:  

Mesh:

Year:  1996        PMID: 8722225

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  5 in total

1.  Mammography in New Hampshire: characteristics of the women and the exams they receive.

Authors:  P A Carney; M E Goodrich; D M O'Mahony; A N Tosteson; M S Eliassen; S P Poplack; S Birnbaum; B G Harwood; K A Burgess; B T Berube; W S Wells; J P Ball; M M Stevens
Journal:  J Community Health       Date:  2000-06

2.  Mammographically detected ductal carcinoma in situ treated with conservative surgery with or without radiation therapy: patterns of failure and 10-year results.

Authors:  L L Kestin; N S Goldstein; A A Martinez; M Rebner; M Balasubramaniam; R C Frazier; J T Register; J Pettinga; F A Vicini
Journal:  Ann Surg       Date:  2000-02       Impact factor: 12.969

3.  Rural-urban differences in secular trends of locoregional treatment for ductal carcinoma in situ: A patterns of care analysis.

Authors:  Danielle Riley; Elizabeth A Chrischilles; Ingrid M Lizarraga; Mary Charlton; Brian J Smith; Charles F Lynch
Journal:  Cancer Med       Date:  2022-02-11       Impact factor: 4.711

4.  Ductal carcinoma in situ of the breast, a population-based study of epidemiology and pathology.

Authors:  A Kricker; C Goumas; B Armstrong
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640

5.  Risk of subsequent invasive breast carcinoma after in situ breast carcinoma in a population covered by national mammographic screening.

Authors:  R Rawal; J Lorenzo Bermejo; K Hemminki
Journal:  Br J Cancer       Date:  2005-01-17       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.